The objective of this paper was to investigate the incidence of myocardial
perfusion defects in patients with systemic lupus erythematosus (SLE) assoc
iated with dysautonomic alterations. Twenty patients without any sign or sy
mptoms of heart disease, selected from a larger population of patients with
SLE, underwent technetium-99m sestamibi (Tc-99m MIBI) single photon emissi
on computed tomography (SPECT), at rest and after dipyridamole infusion; th
ey also underwent heart rate variability (HRV) examination by a 24 hour amb
ulatory electrocardiography, analyzing in the time domain the standard devi
ation of the R-R intervals average (SDNN) and the percentage of R-R adjacen
t intervals differing from each other more than 50 msec (pNN50); in the fre
quency domain the low (LF) and high frequencies (HF) were analyzed. Twenty
healthy volunteers served as control group for heart rate variability. At M
IBI-SPECT examination, the scan was found abnormal in 15 patients and norma
l in five: three patients demonstrated reversible defects in the anterosept
al region, four had irreversible defects in a region (two in the anterosept
al region and two in the lateral region), two had rest defects in two diffe
rent regions (lateral and inferior, lateral and anteroseptal) that improved
during dipyridamole scan, and six had both reversible and irreversible def
ects: four in a single segment (three anteroseptal and one lateral, and two
in two different regions, particularly anteroseptal and lateral, lateral a
nd inferior). All 20 patients showed significantly lower HRV parameters in
comparison with the control group, except for pNN50, which indicates decrea
sed physiologic periodic fluctuations of the autonomic nervous system. In s
ix patients who underwent coronary angiography, the epicardial vessels were
found completely normal. In view of the high incidence of myocardial hypop
erfusion in patients with HRV alterations, the authors hypothesize that aut
onomic dysfunction may be associated with microvascular disease or metaboli
c alteration. They also believe that MIBI scintigraphy is a suitable techni
que in detecting myocardial damage in SLE patients free of clinical manifes
tation.